# Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension

> **NCT00730067** · PHASE4 · WITHDRAWN · sponsor: **University of Aarhus**

## Conditions studied

- COPD
- Pulmonary Hypertension

## Interventions

- **DRUG:** sildenafil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00730067
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-06
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** As a single center, it was not possible to recruit enough patients with pulmonary hypertension
- **Last updated:** 2012-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00730067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00730067, "Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00730067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*